Intravenous labetalol in hypertensive patients given by fast and slow injection
- PMID: 350248
- PMCID: PMC1429349
- DOI: 10.1111/j.1365-2125.1978.tb01645.x
Intravenous labetalol in hypertensive patients given by fast and slow injection
Abstract
1 Labetalol reduces blood pressure when given by fast or slow intravenous injection. 2 The extent of the reduction in arterial pressure is independent of the rate of injection but the rate of fall of blood pressure can be controlled by varying the rate of injection. There is little effect on heart rate. 3 These observations suggest that labetalol possesses important advantages over other vasodilator hypotensive drugs in current use.
Similar articles
-
Combined alpha- and beta-receptor inhibition in the treatment of hypertension.Drugs. 1984;28 Suppl 2:51-68. doi: 10.2165/00003495-198400282-00005. Drugs. 1984. PMID: 6151891 Review.
-
Letter: Intravenous labetalol in severe hypertension.Lancet. 1975 Nov 29;2(7944):1093-4. doi: 10.1016/s0140-6736(75)90470-5. Lancet. 1975. PMID: 53581 Clinical Trial. No abstract available.
-
Labetalol infusion in hypertensive emergencies.Clin Pharmacol Ther. 1985 Jun;37(6):615-8. doi: 10.1038/clpt.1985.98. Clin Pharmacol Ther. 1985. PMID: 3891186 Clinical Trial.
-
Intravenous labetalol in the treatment of severe hypertension and hypertensive emergencies.Am J Med. 1983 Oct 17;75(4A):95-102. doi: 10.1016/0002-9343(83)90141-9. Am J Med. 1983. PMID: 6139020 Clinical Trial.
-
Pharmacology of combined alpha-beta-blockade. II. Haemodynamic effects of labetalol.Drugs. 1984;28 Suppl 2:35-50. doi: 10.2165/00003495-198400282-00004. Drugs. 1984. PMID: 6151890 Review.
Cited by
-
Comparison of labetalol with other anti-hypertensive drugs.Br J Clin Pharmacol. 1982 Jun;13(1 Suppl):41S-47S. doi: 10.1111/j.1365-2125.1982.tb01888.x. Br J Clin Pharmacol. 1982. PMID: 6124265 Free PMC article. Review.
-
Hypertensive emergencies and urgencies: definition, recognition, and management.J Gen Intern Med. 1988 Jan-Feb;3(1):64-74. doi: 10.1007/BF02595759. J Gen Intern Med. 1988. PMID: 3123620 Review. No abstract available.
-
Combined alpha- and beta-receptor inhibition in the treatment of hypertension.Drugs. 1984;28 Suppl 2:51-68. doi: 10.2165/00003495-198400282-00005. Drugs. 1984. PMID: 6151891 Review.
-
Comparison of effects on cerebral blood flow of rapid reduction in systemic arterial pressure by diazoxide and labetalol in hypertensive patients: preliminary findings.Br J Clin Pharmacol. 1979;8(Suppl 2):195S-198S. Br J Clin Pharmacol. 1979. PMID: 526401 Free PMC article. Clinical Trial.
References
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources